Neuromuscular block in patients 80 years and older: a prospective, controlled study.

Area of Science:

• Anesthesiology
• Pharmacology
• Geriatric Medicine

Background:

• Increasing number of patients over 80 years undergoing anesthesia.
• Limited data on neuromuscular blocking agent pharmacodynamics in the elderly.
• Need to understand rocuronium's effects in older populations.

Purpose of the Study:

• Compare the time course of rocuronium-induced neuromuscular block in patients aged 80 years and older versus younger adults.
• Evaluate onset time and duration of action of rocuronium in different age groups.

Main Methods:

• Total intravenous anesthesia with propofol and sufentanil.
• Acceleromyography used to assess neuromuscular block.
• Rocuronium 0.6 mg/kg bolus administered to patients aged ≥80 and 20-50 years.

Main Results:

• Onset time was significantly longer in the ≥80 group (190s ± 46s) vs. 20-50 group (123s ± 40s).
• Clinical duration was longer in the ≥80 group (52 min) vs. 20-50 group (36 min).
• Duration to 90% and 100% recovery was significantly prolonged in elderly patients.

Conclusions:

• Rocuronium exhibits a slower onset and longer duration of action in patients ≥80 years compared to younger adults.
• Pharmacodynamic effects of rocuronium are altered in the elderly population.
• Consideration of age-adjusted dosing or alternative agents may be necessary for geriatric anesthesia.